200 related articles for article (PubMed ID: 2430058)
1. Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system.
Memo M; Castelletti L; Missale C; Valerio A; Carruba M; Spano PF
J Neurochem; 1986 Dec; 47(6):1689-95. PubMed ID: 2430058
[TBL] [Abstract][Full Text] [Related]
2. Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary.
Memo M; Castelletti L; Valerio A; Missale C; Spano PF
J Neurochem; 1986 Dec; 47(6):1682-8. PubMed ID: 2430057
[TBL] [Abstract][Full Text] [Related]
3. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
[TBL] [Abstract][Full Text] [Related]
4. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
Valerio A; Alberici A; Tinti C; Spano P; Memo M
J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
Lafond J; Ducharme JR; Collu R
Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
7. The dynamics of arachidonic acid liberation and prolactin release: a comparison of thyrotropin-releasing hormone, angiotensin II, and neurotensin stimulation in perifused rat anterior pituitary cells.
Ross PC; Judd AM; MacLeod RM
Endocrinology; 1988 Nov; 123(5):2445-53. PubMed ID: 3139397
[TBL] [Abstract][Full Text] [Related]
8. Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors.
Wang X; Sato N; Greer MA; Falardeau P
Mol Cell Endocrinol; 1995 Aug; 112(2):153-7. PubMed ID: 7489818
[TBL] [Abstract][Full Text] [Related]
9. Sodium ions: their role and mechanism of action in the control of prolactin release.
Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
[TBL] [Abstract][Full Text] [Related]
10. Interactions of dopamine and neurotensin on calcium fluxes and prolactin release in normal rat pituitary cells.
Login IS; Kuan SI; Judd AM; MacLeod RM
Endocrinology; 1990 Oct; 127(4):1948-55. PubMed ID: 1698150
[TBL] [Abstract][Full Text] [Related]
11. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses.
Mau SE
J Mol Endocrinol; 1997 Jun; 18(3):181-91. PubMed ID: 9195472
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
13. Influence of corticosteroids on prolactin release from anterior pituitary cell aggregates cultured in serum-free medium. Differential effects on dopamine-induced inhibition, post-dopamine rebound and stimulation by TRH, vasoactive intestinal peptide (VIP), angiotensin II and isoproterenol.
Denef C; Schramme C; Baes M
J Steroid Biochem; 1984 Jan; 20(1):197-202. PubMed ID: 6423898
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
16. The possible involvement of both calcium and cyclic AMP in the dopaminergic inhibition of prolactin secretion.
Merritt JE; Brown BL
Life Sci; 1984 Aug; 35(7):707-11. PubMed ID: 6206370
[TBL] [Abstract][Full Text] [Related]
17. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
Enjalbert A; Musset F; Chénard C; Priam M; Kordon C; Heisler S
Endocrinology; 1988 Jul; 123(1):406-12. PubMed ID: 2454806
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic reduction of intracellular calcium: the role of calcium influx.
Login IS; Judd AM; MacLeod RM
Biochem Biophys Res Commun; 1988 Mar; 151(2):913-8. PubMed ID: 3348820
[TBL] [Abstract][Full Text] [Related]
19. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
Martínez de la Escalera G; Guthrie J; Weiner RI
Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
